Skip to main content
. Author manuscript; available in PMC: 2010 Jul 29.
Published in final edited form as: Arch Otolaryngol Head Neck Surg. 2008 Jan;134(1):39–44. doi: 10.1001/archoto.2007.10

Table 3.

MUC2 Expression Levels by Run of RT-PCRa

Run Sample MUC2 Expression Fold Increase
Run 1 CI-01 3.59
CI-02 0.35
CI-03 0.80
RecOM-1 11.40 7.22
RecOM-2 15.05 9.52
RecOM-3 1.16 0.73
OME-1 51.20 32.41
OME-2 36.62 23.18
OME-3 13.72 8.68
OME-4 7.35 4.65
Run 2 CI-04 0.20
CI-05 1.03
CI-06 4.85
RecOM-4 1.36 0.67
OME-5 3.76 1.85
OME-6 2.72 1.34
OME-7 3.51 1.73
Run 3 CI-05 3.59
CI-06 0.35
RecOM-5 11.58 5.88
RecOM-6 2.96 1.50
RecOM-7 2.83 1.44
RecOM-8 30.57 15.52
RecOM-9 13.94 7.08
RecOM-10 2.64 1.34
Run 4 CI-14 0.27
CI-15 2.24
RecOM-11 17.54 13.98
RecOM-12 1.89 1.50
OME-8 1.50 1.19
OME-9 2.86 2.27
Run 5 CI-05 0.48
CI-06 6.79
CI-14 2.87
CI-15 1.08
CI-19 1.17
RecOM-13 12.97 5.23
RecOM-14 10.29 4.15
RecOM-15 2.00 0.81
RecOM-16 18.34 7.40
RecOM-17 2.96 1.19
OME-10 6.26 2.53

Abbreviations: CI, cochlear implant controls; OME, otitis media with effusion; RecOM, recurrent otitis media; RT-PCR, reverse transcription–polymerase chain reaction.

a

MUC2 expression levels by run of real-time RT-PCR. MUC2 values represent the comparison of threshold cycle of MUC2 to the housekeeping gene HPRT for each sample.7 “Fold increase” indicates the fold increase of each sample over the mean of CI samples for that run of real-time RT-PCR.